Compare PHAR & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAR | LEU |
|---|---|---|
| Founded | 1988 | 1998 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 4.1B |
| IPO Year | 2020 | 1998 |
| Metric | PHAR | LEU |
|---|---|---|
| Price | $12.62 | $172.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | $38.33 | ★ $255.55 |
| AVG Volume (30 Days) | 10.2K | ★ 873.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.45 |
| Revenue | N/A | ★ $193,000,000.00 |
| Revenue This Year | $10.04 | $3.76 |
| Revenue Next Year | $2.51 | $6.04 |
| P/E Ratio | $3,041.22 | ★ $375.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.54 | $90.83 |
| 52 Week High | $21.34 | $464.00 |
| Indicator | PHAR | LEU |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 38.90 |
| Support Level | $11.43 | $163.69 |
| Resistance Level | $17.41 | $225.01 |
| Average True Range (ATR) | 0.50 | 13.95 |
| MACD | -0.18 | -4.79 |
| Stochastic Oscillator | 21.71 | 11.60 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.